J&J ordered to pay $417 million in trial over talc cancer risks

(Reuters) - Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene.

J&J ordered to pay $417 million in trial over talc cancer risks
Read More


Bagikan Berita Ini